Sinopia Biosciences
The AI engine Fit Assessment
BetaSinopia Biosciences effectively leverages machine learning and multi-omics data to discover new patterns and expand therapeutic options, optimizing the drug discovery process.
Blurb
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
HQ Location
San Diego (United States)
Founded
2014
Employees
1 - 10
Total funding raised
$17.36M
Funding Status
Grant, $400.00K, March 24, 2026
Subspaces
- Drug Discovery Optimization
Sinopia Biosciences, Inc. is a privately held biotechnology company advancing novel therapeutics using its proprietary LEADS® (LEarn And DiScover) drug discovery platform. Sinopia’s LEADS® platform integrates high-throughput omics data, AI/machine learning, and network analyses. Sinopia is advancing multiple first-in-class programs with high unmet need, including its lead program for Parkinson’s disease. Sinopia is headquartered at JLABS in San Diego, California.